AstraZeneca Highlights Lung Cancer Treatment Study Findings Presented at ESMO

AstraZeneca US Head of Medical Affairs Oncology Camille Hertzka shares the pharma company's most recent lung cancer treatment study findings and insights on the changing landscape of lung cancer treatment driven by precision medicine.

Episode Resources

• Connect with Arundhati Parmar
• aparmar@medcitynews.com 
• https://twitter.com/aparmarbb?lang=en
• https://medcitynews.com/
• Connect with Camille Hertzka 
• camille.hertzka@astrazeneca.com